Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Cell Secretomes Used as Sole Building Blocks Enable The Fabrication of Stable Hydrogels for Biomedical Applications

January 2026 Bioprinting, Bioprocessing, Blood, Cell Therapy, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Tissue Engineering

A Novel Rheumatoid Arthritis 3D Bone-Cartilage Interface for Discovering New Therapeutics

December 2025 Bioprinting, Bioprocessing, Blood, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

Unlocking The Potential of Extracellular Vesicles: One Stimulus Away From Clinical Implementation

November 2025 Bioprocessing, Blood, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles

Exosome-Based Drug Delivery: a Next-Generation Platform for Cancer, Infection, Neurological and Immunological Diseases, Gene Therapy and Regenerative Medicine

October 2025 Bioprinting, Bioprocessing, Blood, Cancer, Cell Therapy, Clinical, Dermal and Wound, Drug Screening, Exosomes / Extracellular Vesicles, Gene Editing, Immunomodulation, MedTech, Devices, & Materials, Tissue Engineering

Modeling Integration Site Data for Safety Assessment With MELISSA

August 2025 Bioprocessing, Blood, Cell Therapy, Clinical, Gene Editing

Development of a High-throughput Morphological Assay for Evaluating Mesenchymal Stromal Cell-derived Extracellular Vesicle Modulation of Brain Pericyte Secretory Phenotype

August 2025 Bioprocessing, Blood, Cell Therapy, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation

Multi-niche Human Bone Marrow On-A-Chip for Studying The Interactions of Adoptive CAR-T Cell Therapies With Multiple Myeloma

May 2025 Bioprinting, Bioprocessing, Blood, Cancer, Cardiovascular, Cell Therapy, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

Developing and Validating Brain Tumor Organoid Models To Evaluate Novel Therapeutics in Vitro

April 2025 Bioprinting, Bioprocessing, Blood, Cancer, Cell Therapy, Clinical, Tissue Engineering

CYR61 Delivery Promotes Angiogenesis During Bone Fracture Repair

April 2025 Blood, Cardiovascular, Cell Therapy, Orthopedic

Good Manufacturing Practice-grade fibronectin for hollow-fiber bioreactor cell manufacture: a mesenchymal stromal cell case study

December 2024 Bioprinting, Bioprocessing, Blood, Cell Therapy, Clinical, Gene Editing, Tissue Engineering
1 2 3 4 5 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email